Healthy Clinical Trial
Official title:
Predicting Central Pain Among People With a Spinal Cord Injury by Evaluating Mechanisms Regulating Pain and Efficacy Testing of the TENS Apparatus
Verified date | August 2018 |
Source | Sheba Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
People with a Spinal Cord Injury can develop chronic pain within months of the injury. Up to
80% of the patients will develop chronic pain called "central pain" and describe the pain as:
burning, stabbing, or "like electricity." Central pain mechanism is unknown and therefore
treatment is currently not effective.
It is hypothesized that chronic pain is associated with impaired function of the systems
regulating pain, however, this hypothesis has not been tested among Spinal Cord Injury
patients. Presence of such a connection, between the regulating system dysfunction and
central pain, will help both predicting the risk of central pain and develop a treatment.
The current research objective is to make several sensory measurements which will measure the
functioning mechanisms of regulation and control of the pain. These measurements are accepted
throughout the world and are based on psychophysical assessment of patients. these
Measurements are designed to assess whether Spinal Cord Injury chronic central pain patients
demonstrate impairment in the regulation of pain. Finding such a link between central pain
and impaired regulation could shed light on the mechanism of central pain. In addition, these
measurements are designed to assess whether fresh spinal cord injury patients that have not
yet developed central pain demonstrate impairment in the regulation of pain immediately after
the injury. By repeated assessments of pain regulation capabilities, which will be made to
fresh Spinal Cord Injury patients during the first months of injury, and comparing the
results of these measurements between those who will develop center pain and those who will
not, we could identify indicators for predicting the risk of central pain. Another goal of
the study is to investigate the efficacy of central pain treatment, using a TENS, when the
parameters of the TENS treatment will be built according to the level of functioning of the
regulating systems of the individual.
Status | Enrolling by invitation |
Enrollment | 120 |
Est. completion date | August 2019 |
Est. primary completion date | August 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - for all subjects: - age - 18-70 - Cognitive status that allows voluntary cooperation understanding of instruction - for chronic Spinal Cord Injury subjects: - spinal cord injury (complete and incomplete) - height of injury - under 7th cervical vertebra - time since injury - one year or more. - for chronic Spinal Cord Injury subjects: - spinal cord injury (complete and incomplete) - height of injury - under under 7th cervical vertebra - time since injury - three weeks or less Exclusion Criteria: - subjects suffering from the following conditions: pacemaker,pregnancy,cancer, tuberculosis, thrombosis, metallic implants - systemic diseases that affect the sensory perception (such as diabetes) - patients with other neurological pathologies (such as head injury-TBI) - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Israel | Sheba Medical Center rehabilitaion facility | Ramat Gan |
Lead Sponsor | Collaborator |
---|---|
Sheba Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensitivity to thermic pain | Minimum temperature at which the patient reported pain. The subject will press a button once feeling pain. pain will be reported using a visual analog scale - a pain scale between 1-10. | 5 minutes | |
Primary | Pain suppression capability | Reduction of pain in the presence of another stimulus. pain will be reported using a visual analog scale - a pain scale between 1-10. | 5 minutes | |
Primary | Habituation to tonic stimulation | Gradient decrease in pain rating. pain will be reported using a visual analog scale - a pain scale between 1-10. | 5 minutes | |
Primary | Temporal summation of pain | Standard rating of pain among several stimuli. pain will be reported using a visual analog scale - a pain scale between 1-10. | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |